前收市價 | 20.14 |
開市 | 19.97 |
買盤 | 19.00 x 800 |
賣出價 | 20.00 x 1000 |
今日波幅 | 19.33 - 20.00 |
52 週波幅 | 19.33 - 109.52 |
成交量 | |
平均成交量 | 474,796 |
市值 | 215.572M |
Beta 值 (5 年,每月) | 1.18 |
市盈率 (最近 12 個月) | 3.18 |
每股盈利 (最近 12 個月) | 6.19 |
業績公佈日 | 2024年8月05日 - 2024年8月09日 |
遠期股息及收益率 | 6.60 (33.49%) |
除息日 | 2023年9月18日 |
1 年預測目標價 | 21.25 |
Medifast (MED) battles persistent customer acquisition challenges aggravated by macroeconomic factors and the rising popularity of weight loss medications.
Whether investors refer to them as undervalued or hidden gems, underappreciated stocks are always worth considering. Investors have made fortunes, large and small, by identifying underappreciated shares and investing their capital. In this article, I’ve identified seven such stocks with 25% returns or greater per consensus forecast. I’ve also filtered for shares with more than five analysts covering the equity. The result is that most of these opportunities are relatively well-known names with r
As inflation remains increasingly sticky, finding undervalued stocks to buy has become increasingly difficult. Meme stocks like GameStop (NYSE:GME) continue climbing despite rapidly approaching market saturation, which could leave retail traders holding the bag when the music stops. Even if inflation cools consistently, goods and services remain significantly higher than two years ago. This discrepancy arises because inflation measures ongoing price growth rather than actual price levels, result